Article
Inhibition of ULK1 promotes the death of leukemia cell in an autophagy irrelevant manner and exerts the antileukemia effect
1 Jan 2021
Abstract excerpt
Because of disease relapse and drug resistance, patients with various subtypes of acute myeloid leukemia (AML) suffer low rate of 5-year survival. Although our understanding of the molecular pathogenesis of AML has made progress, there is a real need to develop new therapeutic targets and drugs to target leukemia for improving the treatment of patients with AML.1 As the homologous of autophagy-related 1 (ATG1),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
